Resolution of Paraneoplastic Alopecia Areata Following Nivolumab in a Patient With Metastatic Melanoma

    June 2023 in “ JAAD case reports
    Sophia Wix, Jade Homsi, Jennifer G. Gill
    Image of study
    TLDR Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.
    A 48-year-old man with metastatic melanoma and paraneoplastic alopecia areata (AA) unresponsive to standard treatments experienced hair regrowth and full resolution of AA within 6 months of starting nivolumab, an immune-checkpoint inhibitor. This case suggests that successful cancer treatment with immunotherapy can resolve associated autoimmune conditions like AA, indicating a potential link between melanocytic antigens in hair follicles and AA pathogenesis. Further research is needed to understand the autoepitopes involved and the role of immunotherapy in treating paraneoplastic autoimmune events.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    0 / 0 results
    — no results

    Related Research

    1 / 1 results